The Orthopedic Biomaterial Market Is Projected To Grow At A CAGR Of 10.3% During The Forecast Period

The global Orthopedic Biomaterial Market was worth USD 11.96 billion, and it is expected to grow at a CAGR of 10.3% over the projected period. The rising prevalence of musculoskeletal disorders and chronic skeletal problems increases product demand, promoting market growth. The growing senior population, which is more vulnerable to chronic diseases, will likely drive up demand even further.

This is due to the growing senior population, increased musculoskeletal injury rates, and increased number of patients seeking knee replacement, construction, and other joint-related orthopaedic surgeries. As the world's senior population grows, more people are likely to have joint disorders, boosting the market's growth. Furthermore, an increase in the number of sports injuries, an increase in the number of trauma cases from an accident, and an increase in orthopaedic procedures such as joint reconstruction and joint arthroplasty are all driving the Orthopedic Biomaterial Market revenue growth. The absence of reimbursement connected with these orthopaedics, on the other hand, may limit the Orthopedic Biomaterial Market to some extent.

Ceramics and bioactive glasses are expected to expand in popularity in the future, owing to their increasing use in operations such as spine surgery and interbody fusion. The segment is also growing due to an increase in synthetic cages and pedicle screws during fixation procedures. The report's overview section examines market dynamics and trends in orthopaedic biomaterials, such as drivers, restraints, and opportunities, that influence the worldwide Orthopedic Biomaterial Market. To fully study the entire competitive scenario in the worldwide orthopaedic biomaterials market, the section also includes revenue estimates, market attractiveness research, and major market share analysis.

The global Orthopedic Biomaterial Market is driven by an increase in the percentage of the population requiring orthopaedic implants, as well as an increase in the incidence rate of injuries related to accidents, sports, and adventure, as well as an increase in the adoption of technologically advanced products and government initiatives to address unmet medical needs. Due to decreased water content, cartilages become more prone to strain and fatigue as they age. As a result, arthritis and other issues develop, necessitating knee replacement surgery. In addition, other connective tissues linked to the bones, such as ligaments, become less flexible and more restricted. The demand for orthopaedic biomaterials among the senior population is predicted to increase due to these reasons.

B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG, Medtronic Plc., Smith & Nephew Plc., Stryker Corp., Victrex Plc., and Zimmer Biomet Holdings Inc., Globus Medical, Heraeus Holding GmbH, Exactech Inc., and Collagen Matrix Inc are the major key players in the Orthopedic Biomaterial Market.